Spero Therapeutics Inc. 宣布,在完成对葛兰素史克(GSK)相关款项的偿还后,公司将有权保留未来与抗生素Utebzi销售相关的后续付款中的35%。
Spero Therapeutics Inc. 宣布,在完成对葛兰素史克(GSK)相关款项的偿还后,公司将有权保留未来与抗生素Utebzi销售相关的后续付款中的35%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.